We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Early Ablation Advantageous in Venous Ulceration

By HospiMedica International staff writers
Posted on 14 Oct 2020
Early endovenous ablation of venous leg ulcerations and superficial venous reflux lead to better outcomes, according to a new study. More...


Researchers at Cambridge University Hospitals (United Kingdom), Imperial College London (Imperial; United Kingdom), and other institutions conducted a multi-center, randomized clinical trial involving 450 patients with venous leg ulceration (of less than six months’ duration) and superficial venous reflux. Patients were randomly assigned to early endovenous ablation (224 patients), or deferred endovenous treatment of superficial venous reflux (226 patients). The primary outcome was time to first ulcer recurrence and ulcer recurrence rate.

The results showed that of the 426 participants whose leg ulcer had healed, 28.4% experienced at least one recurrence during follow-up. There was no clear difference in time to first ulcer recurrence between the two groups, but the rate of recurrent ulcers was 60% higher in the deferred intervention group. In addition, the researchers also reported that healing times were shorter in the early intervention group, compared to the deferred intervention group. The study was published on September 23, 2020, in JAMA.

“Venous leg ulcers cause enormous physical and mental distress to patients, as well as having a financial impact on the National Health Service, which spends around two percent of its budget on managing lower limb wounds, and there is an urgent need to find more effective treatments,” said lead author Alun Davies, MD, of Imperial College London. “Our study is the first to show that early surgical treatment of leg ulcers leads to faster healing and the reduced risk of the ulcer coming back compared to current methods.”

Venous ulcers are the result of superficial venous reflux (also known as varicose veins), and tend to occur on the lower leg, just below the ankle to halfway up the calf. Venous ulcers may develop as a result of any injury to the leg or conditions such as varicose vein, a blood clot, multiple pregnancies, overweight, and standing for long periods of time, such as in work related situations. The ulcers are the result of pooling of fluid in the limb, and may include poor wound healing, edema, restricted mobility due to pain or discomfort when moving, and even amputation.


Related Links:
Cambridge University Hospitals
Imperial College London



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.